- Home
- MTEM vs NURO Comparison
MTEM vs NURO Comparison
Compare MTEM & NURO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEM
- NURO
- Stock Information
- Founded
- MTEM 2001
- NURO 1996
- Country
- MTEM United States
- NURO United States
- Employees
- MTEM N/A
- NURO N/A
- Industry
- MTEM Biotechnology: Biological Products (No Diagnostic Substances)
- NURO Medical/Dental Instruments
- Sector
- MTEM Health Care
- NURO Health Care
- Exchange
- MTEM Nasdaq
- NURO Nasdaq
- Market Cap
- MTEM 9.7M
- NURO 8.2M
- IPO Year
- MTEM N/A
- NURO N/A
- Fundamental
- Price
- MTEM $0.71
- NURO $4.42
- Analyst Decision
- MTEM
- NURO
- Analyst Count
- MTEM 0
- NURO 0
- Target Price
- MTEM N/A
- NURO N/A
- AVG Volume (30 Days)
- MTEM 13.4M
- NURO 14.4K
- Earning Date
- MTEM 11-11-2024
- NURO 11-01-2024
- Dividend Yield
- MTEM N/A
- NURO N/A
- EPS Growth
- MTEM N/A
- NURO N/A
- EPS
- MTEM N/A
- NURO N/A
- Revenue
- MTEM $25,470,000.00
- NURO $4,383,614.00
- Revenue This Year
- MTEM N/A
- NURO N/A
- Revenue Next Year
- MTEM N/A
- NURO N/A
- P/E Ratio
- MTEM N/A
- NURO N/A
- Revenue Growth
- MTEM N/A
- NURO N/A
- 52 Week Low
- MTEM $0.30
- NURO $2.66
- 52 Week High
- MTEM $6.48
- NURO $5.60
- Technical
- Relative Strength Index (RSI)
- MTEM 38.68
- NURO 65.06
- Support Level
- MTEM $0.31
- NURO $3.96
- Resistance Level
- MTEM $1.34
- NURO $4.69
- Average True Range (ATR)
- MTEM 0.14
- NURO 0.22
- MACD
- MTEM -0.05
- NURO 0.04
- Stochastic Oscillator
- MTEM 34.48
- NURO 82.35
About MTEM Molecular Templates Inc.
Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169.
About NURO NeuroMetrix Inc.
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.